drugset / Trial / NCT02940444

Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery

NCT02940444

Phase 1/2 Unknown 2000 enrolled West China Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Thromboembolism is an important perioperative complication in major thoracic surgery, even though current guidelines have recommended postoperative administration of heparin or LMWH for thromboprophylaxis for those high-risk patients, there are still many cases of thromboembolism. Therefore, as the guideline itself writes, the investigators believe the rational of dose and timing of heparin in thoracic surgery are still not well established. Therefore, the investigators aimed to conduct this randomized controlled study to explore the safety and efficacy of preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery.

Timeline

Start
2016-06
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 5000 iu